Proposed Issue of Employee Options
Release Date: 13/08/2021 8:50am
In accordance with Listing Rule 3.10.3, Pharmaxis advises that the directors have resolved to grant performance rights to the Chief Executive Officer, Other Senior Executive Officers and Other Employees in two tranches under the Company’s employee incentive scheme. The first tranche of performance rights are to Other Senior Executive Officers and Other Employees under the Company’s available issuing capacity and an Appendix 3G will be filed on 13 August 2021. The grant to the Chief Executive Officer and the second tranche grant to Senior Executive Officers and Other Employees require shareholder approval which will be sought at the 2021 annual general meeting of the Company.
Details of the Proposed Grants:
|
|
Tranche #1 |
Tranche #2 |
|
Chief Executive Officer |
- |
2,374,000 |
|
Other Senior Executive Officers |
1,674,400 |
2,511,600 |
|
Other Employees |
2,381,200 |
3,571,800 |
|
Total |
4,055,600 |
8,457,400 |
Read full ASX announcement – pdf
Categories: ASX Announcements